Study guide

11.3 Labor, Delivery & Postpartum Management

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

11.3 Labor, Delivery & Postpartum Management

Key Takeaways Explain This Topic AI

Active phase labor arrest is defined as cervical dilation ≥6 cm with membrane rupture and no cervical progression for ≥4 hours despite adequate uterine contractions (>200 Montevideo units) OR ≥6 hours of inadequate contractions with oxytocin administration, necessitating Cesarean delivery.

Electronic fetal monitoring Category III patterns (absent baseline variability accompanied by recurrent late decelerations, recurrent variable decelerations, or bradycardia, or a sinusoidal pattern) require immediate intrauterine resuscitation and urgent delivery.

Shoulder dystocia management requires the HELPERR protocol, starting with McRoberts maneuver (hyperflexion and abduction of maternal hips) and suprapubic pressure; fundal pressure is strictly contraindicated as it worsens impaction and increases uterine rupture risk.

Postpartum hemorrhage (PPH) is defined as cumulative blood loss ≥1,000 mL or blood loss accompanied by signs/symptoms of hypovolemia within 24 hours of delivery; uterine atony accounts for 70-80% of cases and is managed with bimanual uterine massage, oxytocin (1st line), methylergonovine (contraindicated in hypertension), carboprost (contraindicated in asthma), and misoprostol.

Postpartum endometritis presents with fever (>38.0°C / 100.4°F after 24 hours postpartum), purulent lochia, and uterine tenderness, with Cesarean delivery as the predominant risk factor; first-line antibiotic treatment is intravenous clindamycin plus gentamicin.

Last updated: July 2026

  • Labor, Delivery & Postpartum Management
  • Normal & Abnormal Labor Progress

Labor is defined as progressive cervical effacement and dilation accompanied by regular, painful uterine contractions. Labor is clinically divided into three stages:

First Stage: Onset of labor to complete cervical dilation ( 10 cm ).

Latent Phase: 0 to 6 cm dilation . Characterized by slow cervical change. Prolonged latent phase is defined as >20 hours in nulliparas or >14 hours in multiparas. Management involves rest, hydration, or oxytocin; prolonged latent phase is NOT an indication for C-section.

Active Phase: 6 cm to 10 cm dilation . Characterized by rapid cervical dilation (expected rate ≥1.0 cm/hour in nulliparas, ≥1.2 cm/hour in multiparas).

Active Phase Protraction: Cervical dilation progression slower than expected (<1.0–1.2 cm/hr) after 6 cm. Managed with amniotomy (artificial rupture of membranes) and oxytocin augmentation.

Active Phase Arrest Criteria: Diagnosed when cervical dilation is ≥6 cm with ruptured membranes AND there is no cervical change for ≥4 hours despite adequate uterine contractions ( >200 Montevideo units [MMUs] over a 10-minute window measured by intrauterine pressure catheter) OR no cervical change for ≥6 hours of inadequate contractions despite oxytocin administration. Management of active phase arrest requires Cesarean delivery .

Second Stage: Complete cervical dilation ( 10 cm ) to delivery of the fetus. Prolonged 2nd stage is defined as >3 hours in nulliparas (>4 hours with epidural) or >2 hours in multiparas (>3 hours with epidural).

Third Stage: Delivery of the fetus to delivery of the placenta. Normal duration is <30 minutes . Signs of placental separation include lengthening of the umbilical cord, a sudden gush of blood, and the uterus becoming firm and globular.

Intrapartum Fetal Monitoring & Resuscitation

Electronic fetal monitoring (EFM) evaluates fetal oxygenation during labor by analyzing baseline heart rate, variability, accelerations, and decelerations.

Baseline Fetal Heart Rate (FHR): Normal is 110–160 bpm (bradycardia <110 bpm, tachycardia >160 bpm).

Fetal Heart Rate Variability: Refers to fluctuations in baseline FHR. Moderate variability (6–25 bpm) is the single most reliable sign of adequate fetal central nervous system oxygenation.

Deceleration Types:

Early Decelerations: Symmetrical, gradual decrease in FHR coincident with uterine contraction (nadir matches peak of contraction). Cause: fetal head compression (vagal stimulation). Benign; requires no intervention.

Variable Decelerations: Abrupt decrease in FHR (onset to nadir <30 seconds), dropping ≥15 bpm lasting ≥15 seconds. Cause: umbilical cord compression . Managed with maternal position changes; if recurrent, amnioinfusion (instillation of saline via IUPC) decreases cord compression.

Late Decelerations: Symmetrical, gradual decrease in FHR with nadir occurring after the peak of contraction . Cause: uteroplacental insufficiency (fetal hypoxia). Requires immediate intrauterine resuscitation.

EFM Three-Tier Category System:

Category I (Normal): Baseline 110–160 bpm, moderate variability, absence of late/variable decelerations. Highly predictive of normal acid-base status.

Category II (Indeterminate): Tracings not categorized as I or III (e.g., minimal variability, absent accelerations, recurrent variable decelerations). Requires continued surveillance and intrauterine resuscitation measures.

Category III (Abnormal): Absent baseline variability accompanied by recurrent late decelerations , recurrent variable decelerations , or bradycardia ; OR a sinusoidal pattern . Predictive of abnormal fetal acid-base status (fetal acidemia). Requires immediate intrauterine resuscitation and urgent Cesarean delivery if unresolved.

Intrauterine Resuscitation Protocol:

  • Position patient in left lateral tilt (relieves aortocaval compression by gravid uterus)
  • Administer IV fluid bolus (improves placental perfusion)
  • Administer supplemental oxygen via non-rebreather mask
  • Discontinue oxytocin or uterine stimulants immediately

Administer a tocolytic agent (IV terbutaline) if uterine tachysystole (>5 contractions in 10 minutes) is present

  • Obstetric Emergencies
  • Shoulder Dystocia

Impaction of the anterior fetal shoulder behind the maternal pubic symphysis following delivery of the fetal head. Signs: "Turtle sign" (retraction of fetal head against perineum). High risk of brachial plexus injury (Erb-Duchenne palsy C5-C6), clavicular fracture, and fetal hypoxia.

Management (HELPERR Protocol):

Call for emergency assistance

McRoberts Maneuver (First-line): Hyperflexion and abduction of maternal hips onto the abdomen (flattens sacral promontory and increases anteroposterior pelvic diameter).

Suprapubic Pressure (First-line): Applied dislodging the anterior shoulder laterally behind the pubic symphysis. Applied downward and laterally.

Internal maneuvers: Rubin II / Woods screw maneuver (rotation of fetal shoulders), delivery of posterior arm.

CRITICAL: Fundal pressure is strictly CONTRAINDICATED , as it worsens shoulder impaction and increases uterine rupture risk.

Postpartum Hemorrhage (PPH)

Defined as cumulative blood loss ≥1,000 mL OR blood loss accompanied by signs/symptoms of hypovolemia within 24 hours of delivery. The leading cause of maternal mortality worldwide. Organised by the "4 Ts" :

Tone (Uterine Atony - 70-80% of cases): Soft, boggy, poorly contracted uterus extending above umbilicus.

Trauma (15%): Vaginal, cervical, or perineal lacerations, uterine rupture.

Tissue (10%): Retained placental fragments or placenta accreta.

Thrombin (1%): Coagulopathy (DIC, von Willebrand disease).

Medical Agent Mechanism Dosing / Route Contraindications / Precautions

Oxytocin Pituitary hormone, smooth muscle agonist 10-40 units IV infusion or 10 units IM First-line agent; rapid IV bolus causes hypotension

Methylergonovine Ergot alkaloid, causes tonic uterine contraction 0.2 mg IM every 2-4 hours Contraindicated in Hypertension / Preeclampsia (causes severe vasoconstriction)

Carboprost Tromethamine (PGF2-alpha) Prostaglandin F2-alpha analogue 0.25 mg IM every 15-90 mins (max 2 mg) Contraindicated in Asthma (causes severe bronchospasm)

Misoprostol (PGE1) Prostaglandin E1 analogue 800-1,000 mcg sublingual or rectal Safe in hypertension and asthma; causes transient pyrexia/chills

Tranexamic Acid (TXA) Antifibrinolytic (inhibits plasminogen) 1 g IV within 3 hours of birth Administer early (<3h) in all PPH cases alongside uterotonics

Uterine Rupture

Complete disruption of all uterine wall layers. Most common in patients with a prior Cesarean delivery undergoing trial of labor after C-section (TOLAC). Classic presentation: sudden severe abdominal pain , loss of fetal station (regression of presenting part), vaginal bleeding , and abrupt fetal bradycardia or Category III tracing. Requires immediate emergency laparotomy, fetal delivery, and uterine repair or hysterectomy.

Postpartum Care & Complications

Postpartum Endometritis: Polymicrobial infection of the decidua/myometrium (anaerobes, GNRs, streptococci). Presentation: fever (>38.0°C / 100.4°F after first 24h postpartum) , uterine tenderness, purulent foul-smelling lochia, and leukocytosis. Cesarean delivery is the single greatest risk factor (10- to 30-fold increased risk compared to vaginal delivery). First-line antibiotic regimen: Intravenous Clindamycin plus Gentamicin (continued until afebrile for 24 hours).

Postpartum Mood Disorders:

Postpartum Blues: Affects up to 80% of mothers. Onset days 2–3 postpartum , peaks day 5, resolves spontaneously within 14 days . Symptoms: mild tearfulness, fatigue, irritability. Management: reassurance and supportive care .

Postpartum Depression: Onset within 12 months postpartum (typically 1–3 months), lasting >2 weeks . Symptoms: depressed mood, anhedonia, sleep disturbance, feelings of worthlessness, impaired bonding with infant. Management: psychotherapy plus SSRIs (Sertraline is preferred in breastfeeding mothers) .

Postpartum Psychosis: Medical emergency occurring in 0.1-0.2% of births. Onset within days to 2 weeks postpartum. Symptoms: visual/auditory hallucinations, delusions (often involving infant harm), severe agitation. Requires immediate inpatient psychiatric hospitalization for mother and infant safety.

Lactational Complications:

Breast Engorgement: Bilateral, symmetric breast swelling, fullness, warmth, and tenderness occurring 2-4 days postpartum. No systemic fever. Treatment: frequent breastfeeding/pumping, cold compresses.

Lactational Mastitis: Unilateral wedge-shaped painful erythema, edema, and induration accompanied by fever (>38.3°C / 101°F), chills, and malaise . Most common pathogen: Staphylococcus aureus . Treatment: Oral Dicloxacillin or Cephalexin for 10-14 days. CONTINUE breastfeeding or pumping from affected breast to prevent milk stasis and abscess formation. [ Cumulative Postpartum Blood Loss ≥1,000 mL ]

  • (or Signs of Hypovolemia)
  • |
  • +-----------------------------------------+-----------------------------------------+
  • | |
  • [ Initial Resuscitation & Assessment ] [ Palpate Uterine Fundus ]
  • Call for help / PPH protocol team |
  • Two large-bore IVs (16-18 gauge) +----------------+----------------+
  • IV crystalloid bolus + type & crossmatch blood | |
  • Administer Tranexamic Acid (TXA 1g IV) [ Soft, Boggy Uterus ] [ Firm, Well-Contracted ]
  • | |
  • (Uterine Atony) [ Evaluate Other 4 Ts ]
  • | |- Lacerations (Trauma)
  • v |- Retained Placenta (Tissue)
  • [ Bimanual Uterine Massage ] |- Coagulopathy (Thrombin)
  • |
  • [ Oxytocin IV Infusion ]
  • (1st-Line Uterotonic)
  • |
  • +-----------+----------+
  • | Still Bleeding? |
  • +-----------+----------+
  • |
  • +----------------------------+----------------------------+
  • | |
  • [ Hypertension Present? ] [ Severe Asthma Present? ]
  • | |
  • +---------------------+---------------------+ +---------------------+--------------------+
  • | Yes | No | | Yes | No |
  • v v v v v v

[ Avoid Methergine ] [ IV/IM Methergine ] [ Avoid Hemabate ] [ Avoid Hemabate ] [ IM Hemabate ] [ Sublingual/Rectal ]

(Give Hemabate or (0.2 mg IM q2-4h) (Give Methergine or (Give Methergine or (0.25 mg IM q15-90m) [ Misoprostol ]

  • Misoprostol) Misoprostol) Misoprostol) (800-1,000 mcg)
  • |
  • +-----------+----------+
  • | Persistent Bleeding? |
  • +-----------+----------+
  • |
  • v
  • [ Intrauterine Balloon Tamponade ]
  • (Bakri Balloon / Uterine Packing)
  • |
  • v
  • [ Surgical Intervention ]
  • (B-Lynch Suture, Uterine Artery
  • Embolization, or Hysterectomy)